Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
217
datasets available to search
ShareScore release 0.9.0
Dataset results
217 results for “Rheumatic Diseases”
Guided Self-Management Intervention Targeting Fatigue in Rheumatic Inflammatory Diseases
ClinicalTrials.gov study NCT03216616. IPD Sharing: NO. Countries: 0. Publications: 0.
Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy
ClinicalTrials.gov study NCT00646178. IPD Sharing: Not stated. Countries: 0. Publications: 0.
National Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treated With Cimzia® or Disease-modifying Antirheumatic Drugs (DMARDs)
ClinicalTrials.gov study NCT01095393. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases
ClinicalTrials.gov study NCT03454932. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Rituximab (RTX) for Disease Modifying Anti Rheumatic Drug (DMARD) Non-responders in Pakistan: The Pakistan Rituximab Study (PARIS)
ClinicalTrials.gov study NCT02731560. IPD Sharing: NO. Countries: 0. Publications: 0.
Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases
ClinicalTrials.gov study NCT07275580. IPD Sharing: NO. Countries: 0. Publications: 0.
The Prevalence of Rheumatic Heart Disease in School Children in Fiji
ClinicalTrials.gov study NCT00779662. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Observational Study of Meloxicam in Mexican Patients With Rheumatic Diseases
ClinicalTrials.gov study NCT02184065. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Gait Profile and Variables in Pediatric Rheumatic Disease Using a Smart Insole System
ClinicalTrials.gov study NCT06705673. IPD Sharing: NO. Countries: 0. Publications: 0.
A Study on Health - Related Quality of Life in Patients With Rheumatic Diseases Taking Tramadol 37.5mg/Acetaminophen 325mg Tablets
ClinicalTrials.gov study NCT00642837. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Ocular Manifestations in Rheumatic Diseases
ClinicalTrials.gov study NCT03753893. IPD Sharing: NO. Countries: 0. Publications: 0.
Mechanism of the anti-inflammatory effect of colchicine in rheumatic diseases
GEO Series GSE4090. Homo sapiens. 16 samples. Type: Expression profiling by array.
Profiling of long non-coding RNAs associated with atrial fibrillation in patients with rheumatic heart valvular disease
GEO Series GSE108660. Homo sapiens. 10 samples. Type: Expression profiling by array; Non-coding RNA profiling by array.
Genomic analysis of lncRNA and mRNA profile in circulating exosomes of patients with rheumatic heart disease
GEO Series GSE130033. Homo sapiens. 6 samples. Type: Expression profiling by array; Non-coding RNA profiling by array.
Dataset related to article "Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases"
<p>This record contains data related to article "Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases"</p> <p>The purpose of this study was to evaluate the efficacy and safety of the Moderna-1273 mRNA vaccine for SARS-CoV-2 in patients with immune-mediated diseases under different treatments. Anti-trimeric spike protein antibodies were tested in 287 patients with rheumatic or autoimmune diseases (10% receiving mycophenolate mofetil, 15% low-dose glucocorticoids, 21% methotrexate, and 58% biologic/targeted synthetic drugs) at baseline and in 219 (76%) 4 weeks after the second Moderna-1273 mRNA vaccine dose. Family members or caretakers were enrolled as the controls. The neutralizing serum activity against SARS-CoV-2-G614, alpha, and beta variants in vitro and the cytotoxic T cell response to SARS-CoV-2 peptides were determined in a subgroup of patients and controls. Anti-SARS-CoV-2 antibody development, i.e., seroconversion, was observed in 69% of the mycophenolate-treated patients compared to 100% of both the patients taking other treatments and the controls (p &amp;lt; 0.0001). A dose-dependent impairment of the humoral response was observed in the mycophenolate-treated patients. A daily dose of &amp;gt;1 g at vaccination was a significant risk factor for non-seroconversion (ROC AUC 0.89, 95% CI 0.80-98, p &amp;lt; 0.0001). Moreover, in the seroconverted patients, a daily dose of &amp;gt;1 g of mycophenolate was associated with significantly lower anti-SARS-CoV-2 antibody titers, showing slightly reduced neutralizing serum activity but a comparable cytotoxic response compared to other immunosuppressants. In non-seroconverted patients treated with mycophenolate at a daily dose of &amp;gt;1 g, the cytotoxic activity elicited by viral peptides was also impaired. Mycophenolate treatment affects the Moderna-1273 mRNA vaccine immunogenicity in a dose-dependent manner, independent of rheumatological disease.</p>
Anakinra (Kineret®) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA)
ClinicalTrials.gov study NCT00117091. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Repository of data collected on the different variables for the psychobiological effects of virtual reality and binaural tones on chronic pain management in paediatric patients with a rheumatic disease.
<p>Data set used to carry out the statistical analysis of the project <strong>Advances in the Cognitive Management of Chronic Pain in Children and Adolescents Through the Use of Virtual Reality Combined with Binaural Beats. </strong></p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.